Drawing for H HYMT HY MEDICAL TECHNOLOGIES

USPTO serial 87722430

H HYMT HY MEDICAL TECHNOLOGIES

Reviewed by CopyMark Law Group

Reg. 5716935Status 710
Filing date
Status date
Registration date
Apr 2, 2019
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with H HYMT HY MEDICAL TECHNOLOGIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joanna Y. Tsai

JOANNA Y. TSAI JYTLAW12636 HIGH BLUFF DR. SUITE 400SAN DIEGO, CA 92130UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biological fungicides; Biological herbicides; Biological implants, namely, a vital processed human or animal connective tissue; Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Biological tissue grafts; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products and preparations for chloasma; Pharmaceutical skin lotions; Alcohol for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bromine for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Creosote for pharmaceutical purposes; Cytostatics for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Ferments for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Flour for pharmaceutical purposes; Iodine for pharmaceutical purposes; Liquorice for pharmaceutical purposes; Meal for pharmaceutical purposes; Menthol for pharmaceutical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pepsins for pharmaceutical purposes; Propolis for pharmaceutical purposes; Starch for pharmaceutical purposes; Turpentine for pharmaceutical purposes; Yeast for pharmaceutical consumptionSECTION 8 - CANCELLEDSep 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2025C8..CANCELLED SEC. 8 (6-YR)—
Apr 2, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 2, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 26, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 23, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 31, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 31, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 7, 2019IUAFUSE AMENDMENT FILED—
Jan 7, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 10, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 15, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 15, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 25, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 9, 2018ALIEASSIGNED TO LIE—
Apr 2, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Apr 2, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 2, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 2, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 27, 2018DOCKASSIGNED TO EXAMINER—
Jan 2, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 30, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance